Production (Stage)
Kewaunee Scientific Corporation
KEQU
$58.45
-$0.69-1.17%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 77.15M | 67.17M | 47.76M | 48.39M | 56.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 77.15M | 67.17M | 47.76M | 48.39M | 56.70M |
| Cost of Revenue | 53.11M | 48.79M | 33.81M | 35.91M | 42.06M |
| Gross Profit | 24.04M | 18.38M | 13.95M | 12.49M | 14.64M |
| SG&A Expenses | 15.54M | 16.13M | 9.52M | 9.91M | 9.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.65M | 64.92M | 43.33M | 45.82M | 51.18M |
| Operating Income | 8.50M | 2.25M | 4.43M | 2.58M | 5.52M |
| Income Before Tax | 7.15M | 1.28M | 3.93M | 2.43M | 1.35M |
| Income Tax Expenses | 2.20M | -108.00K | 916.00K | 192.00K | -9.83M |
| Earnings from Continuing Operations | 4.95M | 1.38M | 3.02M | 2.24M | 11.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -97.00K | -29.00K | -7.00K | -45.00K | -153.00K |
| Net Income | 4.85M | 1.35M | 3.01M | 2.19M | 11.03M |
| EBIT | 8.50M | 2.25M | 4.43M | 2.58M | 5.52M |
| EBITDA | 9.80M | 3.81M | 5.24M | 3.39M | 6.34M |
| EPS Basic | 1.70 | 0.47 | 1.05 | 0.77 | 3.86 |
| Normalized Basic EPS | 1.53 | 0.27 | 0.85 | 0.52 | 1.12 |
| EPS Diluted | 1.63 | 0.45 | 1.01 | 0.74 | 3.71 |
| Normalized Diluted EPS | 1.47 | 0.26 | 0.82 | 0.50 | 1.08 |
| Average Basic Shares Outstanding | 2.85M | 2.87M | 2.87M | 2.85M | 2.86M |
| Average Diluted Shares Outstanding | 2.98M | 3.00M | 2.97M | 2.97M | 2.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |